相似文献
1
Preliminary evaluation of cyclophosphamide (NSC-26271) and cytosine arabinoside (NSC-63878) in acute leukemia of children.
Cancer Chemother Rep. 1969 Oct;53(5):299-303.
2
[Clinical use of cytosine arabinoside in infancy. I. Cytosine arabinoside in the treatment of acute leukosis].
Minerva Pediatr. 1975 Sep 15;27(28):1539-50.
3
Therapy of acute leukemia with the combination of cytosine arabinoside (NSC-63878) and cyclophosphamide (NSC-26271).
Cancer Chemother Rep. 1970 Aug;54(4):255-62.
4
Daunorubicin (NSC-82151), vincristine (NSC-67574), cytosine arabinoside (NSC-63878), and prednisone (NSC-10023) combination therapy for advanced adult acute leukemia.
Cancer Chemother Rep. 1975 Jul-Aug;59(4):757-60.
5
Refractory leukemia treated with cytosine arabinoside and cyclophosphamide.
Cancer. 1973 Aug;32(2):294-7. doi: 10.1002/1097-0142(197308)32:2<294::aid-cncr2820320203>3.0.co;2-x.
6
[Cytosine-arabinoside in the treatment of acute leukemias].
Wien Med Wochenschr. 1972 Apr 8;122(15):203-7.
7
Experience with the use of cytosine arabinoside in adult acute leukaemia.
Med J Aust. 1970 Mar 28;1(13):635-7. doi: 10.5694/j.1326-5377.1970.tb116902.x.
8
[Chemotherapy of acute leukemia].
Dtsch Med Wochenschr. 1967 Dec 29;92(52):2371-5. doi: 10.1055/s-0028-1106151.
9
[Cytosine arabinoside in the treatment of acute childhood leukemia: clinical contribution].
Haematologica. 1972;57(7):397-409.
10
[Therapy of acute leukemia. 4. Remission induction and remission maintenance therapy].
Saishin Igaku. 1971 Oct;26(10):2034-41.
引用本文的文献
1
Leukemia in children.
Calif Med. 1971 Apr;114(4):31-43.
Zotero 插件